Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-027048
Filing Date
2022-11-14
Accepted
2022-11-14 07:45:55
Documents
41
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20220930_10q.htm   iXBRL 10-Q 636710
2 EXHIBIT 31.1 ex_423221.htm EX-31.1 16365
3 EXHIBIT 31.2 ex_423222.htm EX-31.2 14477
4 EXHIBIT 32.1 ex_423223.htm EX-32.1 10377
  Complete submission text file 0001437749-22-027048.txt   3242448

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20220930.xsd EX-101.SCH 31804
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20220930_cal.xml EX-101.CAL 18851
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20220930_def.xml EX-101.DEF 224562
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20220930_lab.xml EX-101.LAB 222878
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20220930_pre.xml EX-101.PRE 242749
35 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20220930_10q_htm.xml XML 351628
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 221380334
SIC: 2834 Pharmaceutical Preparations